2
Clinical Trials associated with Human prothrombin complex (Guangdong Shuanglin)验证人凝血酶原复合物治疗乙型血友病的有效性及安全性的单臂、开放、多中心临床研究
[Translation] A single-arm, open, multicenter clinical study to verify the efficacy and safety of human prothrombin complex therapy in the treatment of hemophilia B
验证人凝血酶原复合物治疗乙型血友病的有效性及安全性,为注册申报生产提供依据。
[Translation] Verify the effectiveness and safety of human prothrombin complex in the treatment of hemophilia B, and provide a basis for registration and production application.
人凝血酶原复合物(PCC)治疗乙型血友病患者的安全性及疗效的多中心、开放性临床研究
[Translation] A multicenter, open-label clinical study on the safety and efficacy of human prothrombin complex (PCC) in the treatment of hemophilia B patients
观察人凝血酶原复合物(PCC)治疗乙型血友病患者的安全性和疗效
[Translation] To observe the safety and efficacy of human prothrombin complex (PCC) in the treatment of patients with hemophilia B
100 Clinical Results associated with Human prothrombin complex (Guangdong Shuanglin)
100 Translational Medicine associated with Human prothrombin complex (Guangdong Shuanglin)
100 Patents (Medical) associated with Human prothrombin complex (Guangdong Shuanglin)
100 Deals associated with Human prothrombin complex (Guangdong Shuanglin)